#BEGIN_DRUGCARD DB04831

# AHFS_Codes:
Not Available

# ATC_Codes:
C03CC02

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Diflurex
Selacryn
Ticrex

# CAS_Registry_Number:
40180-04-9

# ChEBI_ID:
Not Available

# Chemical_Formula:
C13H8Cl2O4S

# Chemical_IUPAC_Name:
2-{2,3-dichloro-4-[(thiophen-2-yl)carbonyl]phenoxy}acetic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 14:55:35 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Ticrynafen, or tienilic acid, is a diuretic drug with uric acid-lowering (uricosuric) action, formerly marketed for the treatment of hypertension. It was withdrawn in 1982, shortly after its introduction to the market, after case reports in the United States indicated a link between the use of ticrynafen and hepatitis. (Manier et al., 1982)

# Dosage_Forms:
Not Available

# Drug_Category:
Antihypertensive Agents
Diuretics
Uricosuric Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
7091125	Manier JW, Chang WW, Kirchner JP, Beltaos E: Hepatotoxicity associated with ticrynafen--a uricosuric diuretic. Am J Gastroenterol. 1982 Jun;77(6):401-4.

# Drug_Type:
Small Molecule
Withdrawn

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Ticrynafen

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17)

# InChI_Key:
InChIKey=AGHANLSBXUWXTB-UHFFFAOYSA-N

# Indication:
For the treatment of hypertension.

# KEGG_Compound_ID:
C11702

# KEGG_Drug_ID:
D02386

# LIMS_Drug_ID:
4831

# Mechanism_Of_Action:
Not Available

# Melting_Point:
149 Â°C

# Molecular_Weight_Avg:
331.171

# Molecular_Weight_Mono:
329.952034848

# Organisms_Affected:
Humans and other mammals

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
4.09

# Predicted_LogS:
-5.1

# Predicted_Water_Solubility:
2.54e-03 g/l

# Primary_Accession_No:
DB04831

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
38409

# PubChem_Substance_ID:
46505485

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C1=CC=CS1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
(2,3-Dichloro-4-(2-thenoyl)phenoxy)acetic acid
(2,3-Dichloro-4-(2-thienylcarbonyl)phenoxy)acetic acid
(2,3-Dichloro-4-(2-thiophenecarbonyl)phenoxy)acetic acid
4-(2-Theonyl)-2,3-dichlorphenoxyessigsaeure [German]
4-(2-Thienylketo)-2,3-dichlorophenoxyacetic acid
Acide tienilique [inn-french]
Acido tienilico [inn-spanish]
Acidum tienilicum [inn-latin]
Thienylic acid
Tienilic acid
Tienilico acido [spanish]

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:45 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Ticrynafen

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
CYP2C9

# Phase_1_Metabolizing_Enzyme_1_ID:
4757

# Phase_1_Metabolizing_Enzyme_1_Name:
Cytochrome P450 2C9

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Cytochrome P450 2C9
MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV
YGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW
KEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS
IIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM
KSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE
TTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID
LLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK
KSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP
PFYQLCFIPV

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P11712

#END_DRUGCARD DB04831
